Most proteomics researchers and industry watchers are probably familiar with ICAT, a tagging technology developed by Ruedi Aebersold’s former laboratory at the University of Washington. By extension, many in the field are probably familiar with the typical complaints — warranted or not — associated with the ICAT reagent technology: It requires a steep learning curve, its affinity selection criteria are arbitrary, and perhaps most importantly, its cost is high.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.